Cardioprotective Therapy in the Practice of an Anaesthesiologist
Research Article
DOI: 10.21661/r-530961
Open Access
- Published in:
- Monthly international scientific journal «Interactive science»
- Author:
- Balan A.V. 1
- Work direction:
- Медицина
- Rating:
- Article accesses:
- 1652
- Published in:
- eLibrary.ru
1 GUZ "Shchekinskaia raionnaia bol'nitsa"
- APA
For citation:
Balan A. V. (2020). Cardioprotective Therapy in the Practice of an Anaesthesiologist. Interactive science, 18-21. https://doi.org/10.21661/r-530961
- Full text
- Metrics
UDC 615.03
DOI: 10.21661/r-530961
Abstract
All components of anaesthesia have a direct or indirect depressing effect on the myocardium and functional activity of the brain. Given the initial failure of the coronary blood flow, life-threatening disorders of the heart are possible. The higher the severity of the underlying disease, the greater the risk of transient neurological deficit, stroke. Extended continuous monitoring of vital functions, careful assessment of the neurological status of the patient with special attention to the level of consciousness, the presence or absence of symptoms of increased ICP is necessary. The purpose of this study is to evaluate the beneficial effect of cardioprotectors Mexicor, Meldonium in the fight against ischemia in patients with CHD, GB in the department of surgical profile. The following methods have been used: review of literature, previously published research papers. Results: this article discusses the main drugs with cardioprotective properties, describes the positive experience of using them by specialists, and proves the effectiveness of using drugs in the long term.
Keywords
References
- 1. Andreeva, N. I., Mukhina, I. V., & Solov'eva, T. I. (2005).Postresuscitative Effects of Mexidole on Myocardial Lipid Composition and Perioxidation. General Reanimatology, 2.
- 2. Baturin, V. A., Fisher, V. V., & Sergeev, S. A. (2016). The influence of premedication containing mexidol on cortisol level and number of β-adrenergic receptors in the postoperative period. Medical News of the North Caucasus, 4.
- 3. Deviatkina, T. A., Lutsenko, R. V., & Vazhnichaia, E. M. (1999). The influence of mexidol and its structural components on carbohydrate contentand lipid peroxidation during acute stress. Problems of Medical Chemistry, 45 (3), 12-18.
- 4. J. Edward Morgan Jr. (2005). Clinical Anesthesiology. M.: Binom.
- 5. Zadionchenko, V. S., Shekhian, G. G., & Ialymov, A. A. (2013). Mesto mel'doniia v metabolicheskoi tsitoprotektsii. Russian Medical Journal, 9, 448-453.
- 6. Bridi, L. L., Dillman, D., & Nurili, S. Kh. (2016). Anesteziologiia v skhemakh i tablitsakh., 162. M.: MEDpress-inform.
- 7. Mal'tseva, L. A., Krasnenko, N. V., & Khalimonchik, V. V. (2007). Predictors of Sudden Cardiac Death during Extracardiac Surgical Interventions. General Reanimatology, 3 (4), 114-118.
- 8. Mikhin, V. P., Volkova, N. A., Sumin, S. A., & Eremin, P. A. (2014). Mildronate potential for cardiac arrhythmia prevention in perioperative period. Cardiovascular Therapy and Prevention, 13 (1), 27-32.
- 9. Mikhin, V. P. (2011). Kardiotsitoprotektory - novoe napravlenie klinicheskoi kardiologii. Arkhiv vnutrennei meditsiny, 1, 9-13.
- 10. Mikhin, V. P., & Savel'eva, V. V. (2009). Rol' kardiotsitoprotektorov v terapii khronicheskoi serdechnoi nedostatochnosti ishemicheskogo geneza. Rossiiskii kardiologicheskii zhurnal, 1 (75), 49-56.
- 11. Registr lekarstvennykh sredstv Rossii RLS. Retrieved from https://www.rlsnet.ru/tn_index_id_41009.htm
- 12. Tolmacheva, E. A. (2020). Spravochnik VIDAL' "Lekarstvennye preparaty v Rossii". M.: Vidal' Rus.
- 13. Statsenko, M. E., Belenkova, S. V., & Sporova, O. E. (2006). Vozmozhnosti primeneniia Mildronata v kompleksnom lechenii khronicheskoi serdechnoinedostatochnosti u bol'nykh sakharnym diabetom tipa 2 v rannem postinfarktnom periode. Journal Biomed., 1 (3), 67-69.
- 14. Sumin, S. A., & Shapovalov, K. G. (2018). Anesteziologiia-reanimatologiia: uchebnik dlia podgotovki kadrov vysshei kvalifikatsii., 713. M.: Meditsinskoe informatsionnoe agentstvo.
- 15. Sumin, S. A., Mikhin, V. P., & Volkova, N. A. (2013). Dynamic of myocardial ischemic events in different periods of general anesthesia during abdominal surgery and possible methods of their profilactics. Journal of Experimental and Clinical Surgery, 2.
- 16. Erstekis, A. G. (2014). Primenenie mel'doniia pri provedenii iskusstvennogo krovoobrashcheniia i v rannem posleoperatsionnom periode u bol'nykh s vrozhdennymi porokami serdtsa. Stendovye doklady - Iskusstvennoe krovoobrashchenie i kardioplegiia. XX Vserossiiskii sezd serdechno-sosudistykh khirurgov 23-26 Nov. 2014..
- 17. Iarokhno, N. N., Rifel', A. A., & Burakov, A. A. (2006). Effektivnost' metabolicheskoi terapii v kompleksnom lechenii infarkta miokarda. The Bulletin of Siberian Branch of Russian Academy of Medical Sciences, 3 (121), 107-111.
- 18. Zhdanov, A. N. (2006). Rol' antioksidantov v obshchei anestezii pri torakal'nykh khirurgicheskikh vmeshatel'stvakh. Rostov n/D.
- 19. Sesti, C., Simkhovich, B. Z., & Kalvinsh, I. (2006). Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics. J Cardiovasc Pharmacol, 47, 493-499.
Comments(0)